rs2020957

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005236.3(ERCC4):ā€‹c.2617A>Gā€‹(p.Ile873Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,614,196 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I873M) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.0057 ( 10 hom., cov: 32)
Exomes š‘“: 0.00057 ( 1 hom. )

Consequence

ERCC4
NM_005236.3 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 1.92
Variant links:
Genes affected
ERCC4 (HGNC:3436): (ERCC excision repair 4, endonuclease catalytic subunit) The protein encoded by this gene forms a complex with ERCC1 and is involved in the 5' incision made during nucleotide excision repair. This complex is a structure specific DNA repair endonuclease that interacts with EME1. Defects in this gene are a cause of xeroderma pigmentosum complementation group F (XP-F), or xeroderma pigmentosum VI (XP6).[provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041839182).
BP6
Variant 16-13948213-A-G is Benign according to our data. Variant chr16-13948213-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 134135.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00571 (869/152310) while in subpopulation AFR AF= 0.0202 (839/41568). AF 95% confidence interval is 0.0191. There are 10 homozygotes in gnomad4. There are 418 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ERCC4NM_005236.3 linkuse as main transcriptc.2617A>G p.Ile873Val missense_variant 11/11 ENST00000311895.8
ERCC4XM_011522424.4 linkuse as main transcriptc.2755A>G p.Ile919Val missense_variant 12/12
ERCC4XM_047433774.1 linkuse as main transcriptc.1828A>G p.Ile610Val missense_variant 8/8
ERCC4XM_011522427.2 linkuse as main transcriptc.1267A>G p.Ile423Val missense_variant 6/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ERCC4ENST00000311895.8 linkuse as main transcriptc.2617A>G p.Ile873Val missense_variant 11/111 NM_005236.3 P1Q92889-1
ERCC4ENST00000682617.1 linkuse as main transcriptc.2755A>G p.Ile919Val missense_variant 12/12
ERCC4ENST00000389138.7 linkuse as main transcriptn.1894A>G non_coding_transcript_exon_variant 6/62
ERCC4ENST00000683962.1 linkuse as main transcriptc.*2311A>G 3_prime_UTR_variant, NMD_transcript_variant 12/12

Frequencies

GnomAD3 genomes
AF:
0.00570
AC:
868
AN:
152192
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0202
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00383
GnomAD3 exomes
AF:
0.00155
AC:
389
AN:
251430
Hom.:
2
AF XY:
0.00130
AC XY:
176
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.0217
Gnomad AMR exome
AF:
0.000520
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000572
AC:
836
AN:
1461886
Hom.:
1
Cov.:
33
AF XY:
0.000532
AC XY:
387
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.0205
Gnomad4 AMR exome
AF:
0.000648
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000225
Gnomad4 OTH exome
AF:
0.00129
GnomAD4 genome
AF:
0.00571
AC:
869
AN:
152310
Hom.:
10
Cov.:
32
AF XY:
0.00561
AC XY:
418
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.0202
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00379
Alfa
AF:
0.00129
Hom.:
1
Bravo
AF:
0.00635
ESP6500AA
AF:
0.0180
AC:
79
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00178
AC:
216
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Xeroderma pigmentosum, group F Benign:2
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 28, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 19, 2017- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenDec 01, 2023ERCC4: BP4, BS1, BS2 -
not specified Benign:1Other:1
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoDec 14, 2018- -
not provided, no classification providedreference populationITMISep 19, 2013- -
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 13, 2024- -
Xeroderma pigmentosum Benign:1
Benign, criteria provided, single submittercurationSema4, Sema4Feb 07, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0042
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
MutationTaster
Benign
1.0
D
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.64
N
REVEL
Benign
0.097
Sift
Benign
0.095
T
Sift4G
Benign
0.092
T
Polyphen
0.0010
B
Vest4
0.083
MVP
0.65
MPC
0.066
ClinPred
0.0091
T
GERP RS
3.9
Varity_R
0.26
gMVP
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2020957; hg19: chr16-14042070; COSMIC: COSV104606362; COSMIC: COSV104606362; API